Absolute lymphocyte count and neutrophil-to-lymphocyte ratios: Overlooked biomarkers in cancer treatment outcomes. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonnews discuss research across multiple tumor types showing that patients maintaining ALC above 1,500 have
